Element Biosciences, has just announced a new technology called Trinity™ that aims to make genomic sequencing easier and faster. Trinity eliminates some of the more complicated and time-consuming steps involved in sequencing by automating parts of the process through Element’s AVITI™ system, offering scientists a more efficient workflow.
The first version of Trinity, launched during Element’s virtual event BEYOND, focuses on exome sequencing. This allows researchers to concentrate on specific genomic regions, which saves time and reduces costs compared to sequencing an entire genome. Initially, Trinity will focus on exomes, but the company plans to expand its use to custom panels for various applications, such as cancer research, respiratory conditions, and minimal residual disease detection.
What makes Trinity stand out is how it simplifies a traditionally complex process that hasn’t seen significant change in the last 20 years. The system combines multiple steps—like capture, wash, and sequencing—into one process using AVITI™, reducing the need for extra equipment and cutting out up to five hours of hands-on work. Trinity also includes a faster hybridization option that can deliver same-day sequencing results, making it especially useful for projects that require quick turnaround.
“Trinity makes the process of hybrid selection sequencing about as easy as creating a sequencing library and pressing start,” said Shawn Levy, Chief Scientific Officer at Element Biosciences. “It changes a workflow that’s been around for a long time.”
Starting today (October 16th 2024), Trinity is available for order and integrates directly with Element’s AVITI™ systems. Element is partnering with Integrated DNA Technologies and Twist Bioscience to supply the tools needed for the workflow.
Molly He, Element’s CEO and co-founder, said that Trinity will save researchers time and let them focus on the most important parts of their work. “We’re committed to making advanced genomic tools more accessible,” she said.
Representatives from IDT and Twist also commented on the collaboration. Linda De Jesus from IDT highlighted how Trinity can help scientists get more precise genomic insights faster, while Twist’s CEO, Dr. Emily M. Leproust, noted that this technology will allow for faster data collection without compromising quality.